22 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Reg. 46191 (September 10, 1991).
(c)The Company and its Affiliates are in compliance
8-K
EX-1.1
ADPT
Adaptive Biotechnologies Corp
16 Jul 20
Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
5:15pm
of 1977, as amended, the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law;
(x)The operations … of money, or anything else of value, to any person in violation of any Money Laundering Laws or any applicable anti-bribery or anti-corruption laws
10-K
zsp gkokgbjwl7lrfz
26 Feb 20
Annual report
4:53pm
424B4
qgbss adll49zzu
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
8jrio7kw5gvodvn13c31
9 Jan 20
Draft registration statement
12:00am
424B4
wz282
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
EX-10.1
ns8kl233bwu0rt5wh7dj
30 May 19
IPO registration
5:20pm
S-1
f6h518jovr 52iu
30 May 19
IPO registration
5:20pm
S-1
EX-10.4
isaulid6jhjuafb3z
30 May 19
IPO registration
5:20pm
DRS/A
EX-10.1
qpbwgnvaabg47
8 May 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
i7a0p
8 May 19
Draft registration statement (amended)
12:00am